Small intestinal bacterial overgrowth probiotics are increasingly discussed as a potential treatment option for SIBO, a condition where excessive bacteria accumulate in the small bowel, causing bloating, diarrhoea, and malabsorption. Whilst probiotics—live microorganisms that may confer health benefits—are widely available in the UK, their role in managing SIBO remains uncertain. Evidence is mixed, with some studies suggesting symptomatic improvement whilst others show no benefit or even worsening of symptoms. Unlike antibiotics, probiotics lack standardised UK guidelines for SIBO treatment. This article explores how probiotics may help, which strains are researched, potential risks, and when to seek medical advice.

What Is Small Intestinal Bacterial Overgrowth (SIBO)?

Small intestinal bacterial overgrowth (SIBO) is a condition characterised by an abnormally high number of bacteria in the small intestine. Normally, the small bowel contains relatively few bacteria compared to the large intestine, but in SIBO, bacteria from the colon migrate upwards or proliferate excessively in the small intestine. This disrupts normal digestive processes and nutrient absorption.

The condition develops when the body's natural protective mechanisms fail. These mechanisms include gastric acid, which kills ingested bacteria; the migrating motor complex, which sweeps bacteria downwards between meals; and the ileocaecal valve, which prevents backflow from the colon. When these defences are compromised, bacteria can accumulate in the small intestine. Common risk factors include diabetes, scleroderma, previous abdominal surgery, structural abnormalities, proton pump inhibitor (PPI) therapy, and coeliac disease.

Common symptoms of SIBO include:

• Bloating and abdominal distension, often worsening throughout the day

• Diarrhoea or, less commonly, constipation

• Abdominal pain or discomfort

• Excessive flatulence

• Malabsorption leading to weight loss, vitamin deficiencies (particularly B12 and fat-soluble vitamins), and fatigue

Diagnosis typically involves hydrogen and methane breath testing, though this has variable accuracy with potential false positives and negatives. Quantitative culture of jejunal aspirate is the reference standard but is invasive and rarely performed in clinical practice. Breath testing availability varies across NHS trusts. The British Society of Gastroenterology provides guidance on investigation pathways, though NICE does not offer specific SIBO guidance. It is important to distinguish SIBO from other conditions such as irritable bowel syndrome (IBS), coeliac disease, and inflammatory bowel disease, which may present with similar symptoms.

How Probiotics May Help With SIBO

Probiotics are live microorganisms that, when administered in adequate amounts, may confer health benefits to the host. In the context of SIBO, the rationale for probiotic use is based on several proposed mechanisms, though the evidence base remains evolving and somewhat controversial.

One theoretical benefit is competitive inhibition—probiotics may compete with pathogenic bacteria for nutrients and binding sites in the intestinal lining, potentially reducing the overgrowth of harmful species. Certain probiotic strains also produce antimicrobial substances, such as bacteriocins and organic acids, which may inhibit the growth of problematic bacteria in the small intestine.

Some research suggests probiotics may influence intestinal motility. Certain strains have been hypothesised to affect the migrating motor complex, though this effect is not well established in humans with SIBO and varies significantly between different probiotic strains and formulations.

Additionally, probiotics may modulate the immune system and reduce intestinal inflammation, which could be beneficial in SIBO-related gut dysfunction. They may also help support intestinal barrier function, potentially reducing bacterial translocation and associated symptoms.

However, it is crucial to note that the evidence for probiotics in SIBO is mixed. Some studies suggest symptomatic improvement and reduced breath test abnormalities, whilst others show no benefit or even potential worsening of symptoms. The heterogeneity of probiotic strains, dosages, and patient populations makes it difficult to draw firm conclusions. No UK guidelines (NICE/BSG) recommend probiotics as first-line therapy for SIBO, and their use should be considered on an individual basis, ideally under medical supervision.

Which Probiotics Are Recommended for SIBO in the UK?

There is currently no universally recommended probiotic formulation specifically for SIBO in the UK. Unlike antibiotics, which have established protocols for SIBO treatment, probiotics lack standardised guidelines from NICE or the MHRA. Research into specific strains for SIBO remains limited and heterogeneous.

Lactobacillus and Bifidobacterium species are among the most commonly researched. Some small studies have investigated specific strains, such as Lactobacillus casei, Lactobacillus plantarum, and Bifidobacterium lactis, for their potential effects on SIBO symptoms and breath test results. These effects appear to be highly strain-specific rather than applicable to entire bacterial genera.

Saccharomyces boulardii, a probiotic yeast, has also been investigated. As a yeast rather than bacteria, it may have different effects on the gut microbiome compared to bacterial probiotics. It has demonstrated benefits in other gastrointestinal conditions, such as antibiotic-associated diarrhoea and Clostridioides difficile infection, though specific evidence for SIBO is limited.

When selecting a probiotic in the UK, patients should look for products that:

• Clearly identify the genus, species and specific strain(s)

• Provide information on colony-forming unit (CFU) count at end-of-shelf-life, not just at manufacture

• Are manufactured to high quality standards and stored appropriately to maintain viability

• Are purchased from reputable sources, such as pharmacies or established health retailers

It is important to recognise that probiotics are classified as food supplements in the UK, not medicines, and are not subject to the same rigorous regulatory oversight. They cannot make medicinal claims about treating specific conditions. Patients should discuss probiotic use with their GP or gastroenterologist, particularly if they have underlying health conditions or are taking other medications. A healthcare professional can help determine whether probiotics are appropriate and monitor for any adverse effects.

Potential Risks and When Probiotics May Worsen SIBO

Whilst probiotics are generally considered safe for most individuals, they are not without potential risks, particularly in the context of SIBO. Understanding these risks is essential for informed decision-making and safe use.

One concern is that probiotics may paradoxically worsen SIBO symptoms in some patients. Introducing additional bacteria into an already overpopulated small intestine could theoretically exacerbate bloating, gas, and abdominal discomfort. Some individuals report increased symptoms when starting probiotics, which may indicate that the probiotic strain is not suitable or that the bacterial load is being increased rather than balanced.

Patients with severe immunosuppression should exercise caution with probiotics. Although rare, there have been case reports of probiotic-related infections, including bacteraemia and fungaemia, particularly in critically ill or immunocompromised individuals. Those undergoing chemotherapy, taking high-dose corticosteroids, or living with HIV should consult their healthcare provider before using probiotics.

Individuals with central venous catheters or structural heart disease may also be at increased risk of infection from probiotic organisms. Saccharomyces boulardii specifically has been associated with fungaemia in patients with central lines or in critical care settings. Additionally, patients with short bowel syndrome or intestinal dysmotility may experience complications from probiotic use.

Another consideration is D-lactic acidosis, a rare but serious condition that can occur when certain probiotic bacteria produce excessive D-lactate in the gut. This has been reported in patients with short bowel syndrome or other conditions affecting gut transit. Symptoms include confusion, slurred speech, and ataxia.

When to stop probiotics:

• If symptoms significantly worsen after starting probiotics

• If new symptoms develop, such as fever, severe abdominal pain, or signs of infection

• If advised by a healthcare professional

Stop the product and seek urgent medical advice if you develop fever, rigors, or signs of sepsis after starting a probiotic. Patients should always inform their GP or specialist about probiotic use, particularly if undergoing treatment for SIBO or other gastrointestinal conditions.

Other Treatment Options for Small Intestinal Bacterial Overgrowth

The mainstay of SIBO treatment in the UK involves addressing the underlying cause and reducing bacterial overgrowth, typically through antibiotic therapy. Rifaximin, a non-absorbable antibiotic, is commonly used as it acts locally in the gut with minimal systemic absorption. It has demonstrated efficacy in reducing SIBO symptoms and normalising breath tests. However, it is important to note that the use of rifaximin and other antibiotics for SIBO is off-label in the UK and usually initiated by specialists according to local pathways; availability may vary by region.

Other antibiotics, such as metronidazole, ciprofloxacin, or doxycycline, may be used alone or in combination. Ciprofloxacin is subject to MHRA safety restrictions due to rare but serious side effects, and should only be used when other antibiotics are unsuitable. All antibiotics carry risks including Clostridioides difficile infection and antimicrobial resistance. Specific precautions apply to individual antibiotics (e.g., avoiding alcohol with metronidazole, sun protection with doxycycline).

Treatment courses typically last 10–14 days, though some patients require repeated courses if SIBO recurs. Antibiotic treatment does not address underlying predisposing factors, so recurrence is common unless these are managed.

Dietary modifications may help control symptoms. The low-FODMAP diet, which restricts fermentable carbohydrates, may reduce symptoms by limiting substrates for bacterial fermentation. This diet should be implemented under the guidance of a registered dietitian to ensure nutritional adequacy, as recommended by NICE for IBS management. Some patients benefit from a specific carbohydrate diet or elemental diet, though these are more restrictive and require professional supervision.

Addressing underlying conditions is crucial for long-term management. This may involve optimising diabetes control, managing hypothyroidism, treating gastroparesis, or correcting anatomical abnormalities. Prokinetic medications, such as prucalopride (licensed for chronic constipation; off-label for SIBO-related motility issues), may be considered to improve intestinal motility, though evidence for their use in SIBO is limited.

Nutritional support is important, particularly if malabsorption has led to deficiencies. Supplementation with vitamin B12, iron, folate, vitamin D, and other fat-soluble vitamins (A, E, K) may be necessary. Regular monitoring of nutritional status is recommended.

Some patients explore herbal antimicrobials, such as berberine, oregano oil, or neem, though there is limited high-quality evidence supporting their use. These should not replace conventional treatment and should be discussed with a healthcare professional.

When to See a GP About SIBO Symptoms

Patients experiencing persistent or troublesome gastrointestinal symptoms should seek medical advice to ensure appropriate investigation and management. Whilst SIBO is not immediately life-threatening, it can significantly impact quality of life and lead to nutritional deficiencies if left untreated.

You should contact your GP if you experience:

• Persistent bloating, abdominal pain, or altered bowel habits lasting more than a few weeks

• Unexplained weight loss or difficulty maintaining weight

• Signs of malabsorption, such as pale, floating, or foul-smelling stools

• Symptoms of vitamin deficiencies, including fatigue, weakness, numbness, or tingling

• Symptoms that significantly interfere with daily activities or quality of life

Seek urgent medical attention if you develop:

• Severe abdominal pain, particularly if sudden or accompanied by fever

• Persistent vomiting or inability to keep fluids down

• Blood in stools or black, tarry stools

• Signs of severe dehydration, such as dizziness, reduced urine output, or confusion

• Jaundice (yellowing of skin or eyes)

NICE guidance recommends urgent referral for certain symptoms, particularly in older adults, including persistent change in bowel habit, rectal bleeding, and iron-deficiency anaemia, as these may indicate colorectal cancer.

Your GP will take a detailed history and may perform initial investigations, such as blood tests to check for anaemia, vitamin deficiencies, inflammatory markers, and coeliac disease. They may also arrange stool tests to exclude infections or inflammatory bowel disease, and possibly faecal calprotectin to help distinguish between inflammatory bowel disease and irritable bowel syndrome. If SIBO is suspected, referral to a gastroenterologist may be appropriate for specialist assessment and breath testing.

It is important to be open with your GP about any supplements, probiotics, or other non-prescription products you are taking, as this information helps guide treatment decisions. If you experience side effects from any medicines, report them to the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk). If you have been diagnosed with SIBO and symptoms persist despite treatment, or if they recur frequently, further investigation may be needed to identify underlying causes such as structural abnormalities, motility disorders, or immune deficiencies. A multidisciplinary approach involving gastroenterologists, dietitians, and other specialists may be beneficial for complex or refractory cases.

Frequently Asked Questions